Raj Speciality Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.20 Cr
as on 16-11-2024
- Paid Up Capital ₹ 9.58 M
as on 16-11-2024
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.95 Cr
as on 16-11-2024
- Revenue -32.98%
(FY 2023)
- Profit 16.59%
(FY 2023)
- Ebitda -16.30%
(FY 2023)
- Net Worth 6.99%
(FY 2023)
- Total Assets -20.56%
(FY 2023)
About Raj Speciality Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.20 Cr and a paid-up capital of Rs 9.58 M.
The company has closed loans amounting to ₹4.95 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ram Agarwal and Mamta Agarwal serve as directors at the Company.
- CIN/LLPIN
U24110TN2008PTC067966
- Company No.
067966
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 May 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tuticorin, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Raj Speciality Chemicals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ram Agarwal  | Director | 29-May-2008 | Current |
| Mamta Agarwal | Additional Director | 29-May-2008 | Current |
Financial Performance of Raj Speciality Chemicals.
Raj Speciality Chemicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 32.98% decrease. The company also saw a substantial improvement in profitability, with a 16.59% increase in profit. The company's net worth moved up by a moderate rise of 6.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Raj Speciality Chemicals?
In 2023, Raj Speciality Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Jansons Specialities Private LimitedActive 5 years 5 months
Ram Agarwal and Mamta Agarwal are mutual person
- Raj Speciality Products Private LimitedActive 3 years 30 days
Ram Agarwal and Mamta Agarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 24 Jan 2011 | ₹4.95 Cr | Satisfied |
How Many Employees Work at Raj Speciality Chemicals?
Unlock and access historical data on people associated with Raj Speciality Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raj Speciality Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raj Speciality Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
